CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 80 enrolled
Drug / intervention
146-9251 cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03173547
NCT03173547Phase 2Completed

A Randomized, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of 146-9251 Cream Applied Twice-daily for Six Weeks in Subjects With Ichthyosis Vulgaris

Crown Laboratories, Inc.·interventional·Posted Jun 2, 2017·Updated Aug 10, 2021

In Brief

A Phase 2 clinical trial evaluating 146-9251 cream and Vehicle cream for Ichthyosis Vulgaris. Completed, enrolled 80 participants across 7 sites.

Detailed Summary

The objective of this study is to determine and compare the safety and efficacy of topical 146-9251 cream and vehicle cream applied twice daily for 6 weeks in subjects with moderate to severe ichthyosis vulgaris (IV).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedJun 2, 2017
Enrollment StartApr 25, 2017
Primary CompletionApr 30, 2019
Study CompletionJul 31, 2019
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 9.1 years ago

Interventions

146-9251 creamdrug

146-9251 cream contains an active drug and is applied topically.

Vehicle creamdrug

Vehicle cream does not contain an active drug and is applied topically.